Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
6.71
-0.07 (-1.03%)
Aug 26, 2026, 1:55 PM EDT - Market open
Valneva SE Market Cap
Valneva SE has a market cap or net worth of $627.52 million as of August 26, 2026. Its market cap has decreased by -19.56% in one year.
Market Cap
627.52M
Enterprise Value
730.87M
1-Year Change
-19.56%
Ranking
Category
Stock Price
$6.71
ChartMarket Cap Chart
Since the IPO on May 6, 2021, Valneva SE's market cap has decreased from $1.29B to $627.52M, a decrease of -51.45%. That is a compound annual growth rate of -12.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 627.52M | -16.79% |
| Dec 31, 2025 | 754.16M | 107.47% |
| Dec 31, 2024 | 363.50M | -49.80% |
| Dec 29, 2023 | 724.08M | -21.32% |
| Dec 30, 2022 | 920.30M | -68.57% |
| Dec 31, 2021 | 2.93B | 126.51% |
| May 6, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CorMedix | 657.85M |
| Verastem | 646.62M |
| Scribe Therapeutics | 645.73M |
| Prime Medicine | 644.01M |
| Contineum Therapeutics | 641.44M |
| Sagimet Biosciences | 638.99M |
| Autolus Therapeutics | 637.46M |
| Arvinas | 633.59M |